about
Genetic methods in diagnosis of hematooncological disordersChanges in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number.H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy.Bullous pyoderma gangrenosum associated with pancytopenia of unknown origin.The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemiaDanazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.Target Therapy in Hematological Malignances: New Monoclonal Antibodies.Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia.Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?DNA Damage Response Resulting from Replication Stress Induced by Synchronization of Cells by Inhibitors of DNA Replication: Analysis by Flow Cytometry.Cell synchronization by inhibitors of DNA replication induces replication stress and DNA damage response: analysis by flow cytometry.Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia[Acute promyelocytic leukemia--modern approach to disease pathogenesis and differentiation treatment].Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures.Central nervous involvement by chronic lymphocytic leukaemia.Assessment of Apoptosis Regulating Factors BCL-2 and Fas Antigens on Malignant and Normal Plasma Cells.Short Communication: Expression of Apoptosis Regulating Factors on T Lymphocytes in Multiple Myeloma Patients.Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease.T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysisIntracellular cytokine expression by T cells differs in ZAP-70-positive and ZAP-70-negative chronic lymphocytic leukaemia patientsThe clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemiaEditorial: the importance of rational chemotherapy of chronic lymphocytic leukemiaIntraventricular treatment of secondary central nervous system lymphoma - Case study and literature overview
P50
Q26853326-F955C7FB-10C2-43D1-8298-7AB71A76ACECQ33798525-3762FCE0-1596-4017-9154-DCCF1F1C8244Q34089263-2252E6BC-8891-4F0C-878A-7ED2D8A895A8Q34227945-6D00EAF4-77C6-4A1C-A990-95C0321B8B0AQ35941236-5EBE2C97-4677-4478-A457-EA54C4646E21Q36547670-F3AE61A8-6B9A-4456-B714-4BA1945B3548Q36979140-8BBF34A4-EACD-43A3-9A57-9230627E18C9Q37362785-578704A3-C11E-4D94-B724-0C33997ED21BQ38818269-BE0753AF-1B1D-43B7-8174-C9B67EDE15B0Q39213232-BA04CB50-3609-49EB-9F28-2D9109A791BCQ41856204-EB1D7B48-2C24-4935-9BA8-6EF498AFB797Q42159065-671B1C3A-7DF2-4FBC-A03D-108636E3CDEBQ43763884-BC0B7F52-6A45-441F-9B52-B1C19A52539EQ46980065-62E1C715-57E8-48FF-98AC-9CB7745444C9Q47606743-E00C5EA3-AC8D-4D42-A145-78E18B5CE904Q47683400-53C3E22A-E0CE-4308-A105-5035E99C9EE2Q47684184-89C09954-B9CF-4DD4-B146-A6C9D76D7152Q55182677-56EE70B9-D835-4868-B455-28D7C9DD5769Q74086448-9965C06E-69E4-47FE-B8D3-430D2A3C0BB1Q80631953-8DC8A171-0902-4FB1-89DE-B9F91D22A5A3Q82766574-B459C4C6-3B14-4692-B0B9-E30E71C7F32FQ84146204-ECFF4216-C95B-41A8-80BD-5A1E7FB35EC5Q88496899-C0DACCFF-3677-4B02-9A48-A5672C2ADB1A
P50
description
researcher ORCID ID = 0000-0001-9458-0891
@en
name
Monika Podhorecka
@ast
Monika Podhorecka
@en
Monika Podhorecka
@es
Monika Podhorecka
@nl
Monika Podhorecka
@pl
type
label
Monika Podhorecka
@ast
Monika Podhorecka
@en
Monika Podhorecka
@es
Monika Podhorecka
@nl
Monika Podhorecka
@pl
altLabel
Monika Agnieszka Podhorecka
@pl
prefLabel
Monika Podhorecka
@ast
Monika Podhorecka
@en
Monika Podhorecka
@es
Monika Podhorecka
@nl
Monika Podhorecka
@pl
P1153
6603171916
P1559
Monika Podhorecka
@pl
P21
P31
P3124
P496
0000-0001-9458-0891